Dose, duration, adherence, and changes in other medications over time are also important unanswered issues. Researchers say randomized clinical trials will be needed to confirm the findings and better understand how GLP-1 medications may affect cardiovascular risk in people with autoimmune diseases
When you start semaglutide drops for weight loss through our Seattle clinic, its important to stick to your diet and fitness routines
Nommsen-Rivers LA
Help reduce the risk of major cardiovascular events, such as stroke, heart attack, or death for people with known heart disease who meet the criteria for taking semaglutide
Additionally, there is an increased risk of gallbladder problems such as gallstones when taking GLP-1 receptor agonists, especially during periods of rapid weight loss
Versus semaglutide, all tirzepatide doses were associated with numerically higher odds of experiencing severe gastrointestinal AEs and numerically lower odds of all-cause discontinuation